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Introduction {#sec1}
============

Crohn's disease (CD), a subtype of inflammatory bowel disease (IBD), is characterized by a relapse-remitting, discontinuous, and transmural immunopathology of the gastrointestinal tract that primarily affects the terminal ileum in more than 70% of patients ([@bib3]). The continuous global increase in both incidence and prevalence of IBD rates over the last two decades has affected more than three million adults in the US alone ([@bib9]; [@bib34]). The pathogenesis of CD is thought to reflect a complex interplay between environmental factors, the gut microbiota and host genetics with intestinal epithelial barrier dysfunction (IEBD) considered an important risk factor. To date, however, there are no FDA-approved corrective IEBD therapies available ([@bib36]). Therefore, identification of a biologically relevant model to study IEBD and test novel corrective therapies are of great importance in the field of IBD.

Throughout the gastrointestinal tract, a continuous layer of single epithelial cells, derived from a common progenitor LGR5^+^ intestinal stem cell (ISC), act as the essential barrier, between host immune systems and luminal content ([@bib36]). Recent advances in 3D intestinal culture techniques have allowed generation of both human and murine intestinal organoids for disease modeling ([@bib13]; [@bib31]; [@bib44]). However, there are limited data indicating whether small intestinal organoids (enteroids \[EnOs\]), which are composed of only epithelial cells, can recapitulate features of multifactorial CD ([@bib10]; [@bib54]; [@bib56]).

SAMP1/YitFc (SAMP) mice are a unique model of IBD that spontaneously develop CD-like ileitis that closely resembles human CD, with regard to location, histologic features, and extra-intestinal manifestations. SAMP mice present with discontinuous areas of "cobble-stoning" and transmural inflammation located between areas of normal (healthy) gut mucosa within the terminal ileum ([@bib24]; [@bib39]; [@bib41]). Disease occurs in mice with 100% penetrance, within a well-defined time course and is characterized by a "pre-ileitis" phase (at \<10 weeks old), and a "chronic, established ileitis" phase (≥25 weeks old), and is responsive to standard CD therapies, such as anti-tumor necrosis factor alpha (anti-TNF-α) drugs and steroids (e.g., dexamethasone) ([@bib30]; [@bib41]). SAMP mice exhibit small intestine epithelial barrier dysfunction before ileitis onset that eventually leads to infiltration of active and chronic immune cells in the ileum ([@bib24]; [@bib37]).

TNF^ΔARE/+^ (TNF) mice are a genetically driven model of CD-like ileitis characterized by their continuous, aberrant production of TNF-α resulting in intestinal inflammation that is demonstrated as early as birth ([@bib23]). TNF mice bear a deleted repetitive AU-rich motif in the 3′-untranslated region of the TNF-encoding gene. The resulting aberrant TNF production due to enhanced *Tnf* mRNA stability leads to the development of spontaneous inflammation in the terminal ileum ([@bib4]; [@bib23]). Intestinal disease in TNF heterozygotes is characterized by early villous blunting with severe patchy terminal ileitis by 8 weeks of age, and acute and chronic transmural inflammation by 16 weeks, with older mice (5--7 months) displaying loss of villous architecture and granuloma development ([@bib4]; [@bib23]; [@bib43]). Of interest, the selective overexpression of TNF only in the intestinal epithelium appears sufficient to trigger CD-like ileitis ([@bib42]), indicating that epithelium plays an important role in inflammation pathogenesis in TNF mice.

Herein, we sought to determine whether organoids can recapitulate features of CD in two different mouse models of CD-like ileitis (SAMP and TNF mice), each having high clinical relevance to human disease.

Results {#sec2}
=======

Enteroid Formation Is Impaired in Inflammation-free SAMP Mice {#sec2.1}
-------------------------------------------------------------

SAMP mice harbor multiple susceptibility loci on chromosomes 6, 9, and X responsible for the epithelial change and immune regulatory functions ([@bib25]), which together may lead to IEBD preceding onset of histologic inflammation ([@bib37]; [@bib55]). To determine whether defect in EnO formation exists and design an *in vitro* model to closely mimic the pathophysiology of CD, we generated enterospheres (EnSs) and EnOs ([@bib52]) from young, "inflammation-free" (i.e., pre-ileitis) 5-week-old SAMP (SAMP-5) mice and age/sex-matched AKR/J parenteral control mice (AKR-5). The terminal ilea of AKR-5 and SAMP-5 mice had normal histology (i.e., no acute inflammation, chronic inflammation, or villous blunting; [Figures 1](#fig1){ref-type="fig"}A and 1B), along with no increase of proinflammatory cytokines ([Figure 1](#fig1){ref-type="fig"}C) compared with control AKR mice. SAMP-5 EnSs and EnOs had defective morphology ([Figure 1](#fig1){ref-type="fig"}D), 1.6-fold reduced viability (0.8 ± 0.1 versus 1.3 ± 0.2, p \< 0.0004; [Figure 1](#fig1){ref-type="fig"}E) and 1.5-fold smaller surface area (3.9 ± 0.2 versus 2.6 ± 0.5, p \< 0.0001; [Figure 1](#fig1){ref-type="fig"}F) compared with AKR-5 ([Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). SAMP-5 mice also had on average a 1.9-fold lower number of EnSs and EnOs compared with controls, despite starting from an equal crypt count ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2D; [Table S3](#mmc1){ref-type="supplementary-material"}). In addition, after 6 days in culture, SAMP-5-generated EnOs were predominantly cyst-like structures with no crypts, whereas approximately 79% of AKR-5 EnOs displayed *de novo* appearance of two or more crypts with a typical multilobulated organization and only 9% having spherical shape ([Figure 1](#fig1){ref-type="fig"}G; [Table S4](#mmc1){ref-type="supplementary-material"}). Scanning electron microscopy validated our observation, showing multiple branching AKR-5 EnOs compared with a more rudimentary morphology of SAMP-5 EnOs ([Figure 1](#fig1){ref-type="fig"}H).Figure 1Defective EnO Formation in Intestinal Inflammation-free SAMP MiceData, indicated as mean ± SD, correspond to three independent experiments (n = 2 mice/group/experiment).(A) Representative photomicrographs of ileal sections of 5-week-old AKR (AKR-5) and SAMP (SAMP-5) mice. Scale bars, 200 μm. Zoomed images are at 20× magnification.(B) Total inflammatory score of ileal tissue from AKR-5 (0.0 ± 0.0) and SAMP-5 (0.5 ± 0.5).(C--F) (C) Relative expression of indicated cytokine mRNA measured in total tissue RNA extracted from 5-week-old SAMP and AKR ilea. The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^). Small intestinal EnSs and EnOs (D) growth, (E) viability, and (F) size from AKR-5 and SAMP-5 mice after 6 days in culture. Scale bars, 100 μm.(G) Quantification of *de novo* crypt formation at day 6 in EnOs from AKR-5 and SAMP-5 mice.(H) Scanning electron micrographs of EnOs from AKR-5 and SAMP-5 mice at day 6 in culture. Arrows indicate *de novo* crypts. Note the higher number of *de novo* crypts in EnOs from AKR-5 compared with those from SAMP-5.(I--L) (I) OLFM4 and (J) LYSOZYME staining of AKR-5 and SAMP-5 small intestinal crypts. Scale bars, 50 μm. Frequency of live and dead crypt base columnar (CBC) stem cells (Epcam^+^ Ephb2^hi^/CD44^hi^GRP78^low^/CD166^+^ CD24^med^/CD31^−^CD45^−^) and Paneth cells (CD24^hi^UEA^+^/CD31^−^CD45^−^) isolated from (K) crypts and (L) EnOs of 5-week-old SAMP and AKR mice.

Finally, we investigated whether SAMP EnO-impaired morphology was due to loss of ISC or Paneth cell viability which supply essential support to ISCs ([@bib45], [@bib46]; [@bib12]). To this end, we studied by immunohistochemistry staining the expression of OLFM4 (ISC marker) and LYSOZYME (Paneth cell marker). Small intestinal sections from SAMP-5 mice displayed reduced numbers of both ISCs (5.5 ± 0.9 versus 7.0 ± 0.4, p = 0.006; [Figure 1](#fig1){ref-type="fig"}I) and Paneth cells (3.9 ± 0.5 versus 5.1 ± 0.5, p = 0.01; [Figure 1](#fig1){ref-type="fig"}J) compared with those from AKR-5 mice. We confirmed these observations by flow cytometry adopting a combinational cell surface marker-mediated strategy that allows the purification of a highly enriched and homogeneous population of crypt base columnar (CBC) stem cells, transcriptionally and functionally equivalent to the gold standard Lgr5-GFP ISCs ([@bib33]) ([Figures S1](#mmc1){ref-type="supplementary-material"}D and S1E). CBC and Paneth cells isolated from SAMP-5 crypts (33.4% ± 16.9% versus 12.6% ± 5.2% and 72.3% ± 13.1% versus 24.8% ± 6.6%, p \< 0.005; [Figure 1](#fig1){ref-type="fig"}K) and EnOs (25.2% ± 5.3% versus 13.7% ± 2.6% and 33.6% ± 4.3% versus 17.0% ± 4.5%, p \< 0.01; [Figure 1](#fig1){ref-type="fig"}L) exhibited higher percentage of dead cells compared with those from AKR-5 controls. Collectively, these data demonstrate that EnOs from SAMP-5 mice, presenting no histologic inflammation in the ileum, are characterized by impaired formation, defective morphological features, and reduced ISCs and Paneth cell viability compared with those from control AKR mice.

Crypts from the Small Intestine of SAMP Mice with Established Ileitis Do Not Form EnSs and EnOs {#sec2.2}
-----------------------------------------------------------------------------------------------

To assess the effect of chronic inflammation on the ability to form EnOs, we then generated EnOs from highly inflamed SAMP (25-week-old, SAMP-25) mice, as well as from age-matched AKR controls (AKR-25). Ileal tissues from SAMP-25 mice harbored chronic inflammation, villous blunting, and heavy infiltration of inflammatory cells producing proinflammatory cytokines, i.e., *ifn-γ*, *il-4*, and *il-6* ([Figures 2](#fig2){ref-type="fig"}A--2C). Morphologic assessment revealed that, while crypts from AKR-25 mice formed 3D branching EnOs, SAMP-25 crypts from highly inflamed mice were not able to round up to form EnS or EnO structures, and persisted as clusters of single cells that eventually died by day 6 in culture ([Figures 2](#fig2){ref-type="fig"}D--2G and [S2](#mmc1){ref-type="supplementary-material"}E--S2H; [Tables S1--S4](#mmc1){ref-type="supplementary-material"}). Small intestine from SAMP-25 mice displayed reduced number of both ISCs (3.3 ± 1.0 versus 7.2 ± 0.5, p = 0.0001; [Figure 2](#fig2){ref-type="fig"}H) and Paneth cells (2.7 ± 2.0 versus 5.7 ± 1.2, p = 0.01; [Figure 2](#fig2){ref-type="fig"}I) compared with those from AKR-25 mice. In addition, SAMP-25 crypts had a markedly higher percentage of dead cells in CBC stem cell and Paneth cell suspensions compared with control AKR-25 crypts (87.1% ± 2.2% versus 22.8% ± 10.7% and 96.1% ± 0.3% versus 17.5% ± 3.9%, p \< 0.0001; [Figure 2](#fig2){ref-type="fig"}J). Conversely, colon crypts of SAMP-25 mice were able to round up to form colonospheres (CnSs) leading to colonoid (CnO) formation ([Figures S3](#mmc1){ref-type="supplementary-material"}A--S3C), likely because SAMP mice characteristically do not exhibit inflammation in the colon, have normal colon barrier function, and the disease is isolated to the small bowel ([@bib37]). Collectively, our data demonstrate that inflammation correlates with reduced number of viable ISCs and Paneth cells, and impairs the ability of crypts to form organoid structures.Figure 2Crypts from Inflamed SAMP Mice do Not Form EnSs and EnOsData, indicated as mean ± SD, correspond to three independent experiments (n = 1--2 mice/group/experiment).(A) Representative photomicrographs of ileal sections of 25-week-old AKR (AKR-25) and SAMP (SAMP-25) mice. Scale bars, 200 μm. Zoomed images are at 20× magnification.(B) Total inflammatory score of ileal tissue from AKR-25 (0.0 ± 0.0) and SAMP-25 (19.8 ± 2.9) mice.(C--F) (C) Relative expression of indicated cytokine mRNA measured in total tissue RNA extracted from AKR-25 and SAMP-25 ilea. The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^). Small intestinal EnSs and EnOs (D) growth, (E) viability, and (F) size from AKR-25 and SAMP-25 mice after 6 days in culture. Scale bars, 100 μm.(G) Quantification of *de novo* crypt formation at day 6 in EnOs from AKR-25 and SAMP-25 mice.(H and I) (H) OLFM4 and (I) LYSOZYME staining of AKR-25 and SAMP-25 small intestinal crypts. Scale bars, 50 μm.(J) Frequency of live and dead CBC stem cells (Epcam^+^ Ephb2^hi^/CD44^hi^GRP78^low^/CD166^+^ CD24^med^/CD31^−^CD45^−^) and Paneth cells (CD24hiUEA^+^/CD31^−^CD45^−^) isolated from ileal crypts of 25-week-old SAMP and AKR mice.

Multiple Signaling Pathways Contribute to ISC Niche Defect and Enteroid Formation in SAMP Mice {#sec2.3}
----------------------------------------------------------------------------------------------

To further investigate the observed EnO formation defect, we used a high-throughput RNA sequencing (RNA-seq) approach to profile transcriptional ISC niche responses using three independent samples in SAMP and respective parental control (AKR) mouse groups based on a histologically defined total inflammatory score, i.e., SAMP-5 and AKR-25 (inflammation-free), and SAMP-25 ("inflamed") ([Figure 3](#fig3){ref-type="fig"}A). To avoid physical disruption of the ISC niche, laser capture microscopy (LCM) was used to retrieve crypts and crypt-surrounding regions of terminal ileal cryosections ([Figure S4](#mmc1){ref-type="supplementary-material"}A). Expression of a total of 15,637 unique genes was detected in SAMP-25 compared with 15,376 and 15,377 in SAMP-5 and AKR-25, respectively ([Figure 3](#fig3){ref-type="fig"}B). Differentially expressed gene (DEG) analysis identified a total of 671 and 811 genes differentially expressed between SAMP-5 and -25 ISC niches, and between SAMP-25 and AKR-25 ISC niches, respectively ([Figure 3](#fig3){ref-type="fig"}B). To our knowledge, this global gene expression profile analysis is the first to be carried out in the ISC niche of SAMP mice. Unsupervised hierarchical clustering showed clear segregation of the SAMP-25 ISC niche signature compared with AKR-25 mice, while that of SAMP-5 mice exhibited intermediate gene expression dynamics ([Figure 3](#fig3){ref-type="fig"}C, top dendrogram). Multiple gene clusters were up- and downregulated exclusively in SAMP-25 ISC niche, suggesting an inflammation-dependent profile ([Figure 3](#fig3){ref-type="fig"}C, side dendrogram). Other clusters encompassed genes differentially expressed consistently in the SAMP-5 and SAMP-25 ISC niches compared with that of AKR-25 mice, indicate potential for their specificity as CD susceptibility genes in SAMP mice and thus their involvement in disease onset ([Figure 3](#fig3){ref-type="fig"}C, side dendrogram). To further delineate DEG function trends, we carried out gene set enrichment analysis (GSEA) and estimated the degree of functional enrichment in pairwise comparisons between SAMP-25 and the other two mice groups. In agreement with data collected from the inflamed ileum of CD patients ([@bib1]; [@bib49]), the SAMP-25 ISC niche was enriched in genes involved in inflammatory responses (i.e., myogenesis, coagulation, estrogen response, vascular endothelial growth factor signaling, hypoxia, or glycolysis) compared with that of SAMP-5 and AKR-25 mice (p~adj~ ≤ 0.05, normalized enrichment scores \[NES\] ≥ 1.3; [Figures 3](#fig3){ref-type="fig"}D, 3E, [S5](#mmc1){ref-type="supplementary-material"}A--S5G, and S5H; [Table S6](#mmc1){ref-type="supplementary-material"}). By contrast, other pathways involved in cell metabolism were found depleted in the SAMP-25 ISC niche compared with that of SAMP-5 and AKR-25 mice (p~adj~ ≤ 0.03, NES ≤ −1.4), including lipid and fatty acid metabolism (adipogenesis, fatty acid metabolism, and peroxisome), cell-cycle metabolism (G2M checkpoint, E2F targets, and MYC targets; apoptosis), cell defense (interferon- γ \[IFN-γ\], IFN-α), and cellular energy machinery (oxidative phosphorylation and mitochondrial energy metabolism) ([Figures 3](#fig3){ref-type="fig"}D, 3E and [S5](#mmc1){ref-type="supplementary-material"}D, S5E; [Table S6](#mmc1){ref-type="supplementary-material"}).Figure 3Characterization of Mucosal Gene Expression and Functional Categorization Enrichment of Differentially Expressed Genes in the Ileal ISC Niche of SAMP MiceData, indicated as mean ± SD, correspond to three independent experiments (n = 1 mouse/group/experiment).(A) Total inflammatory score of ileal tissue from AKR-5 (0.0 ± 0.0), SAMP-5 (0.5 ± 0.5), and SAMP-25 (19.8 ± 2.9) mice.(B) Pie chart indicating differentially expressed genes (DEGs) in the three groups.(C--E) (C) Heatmap and hierarchical tree comparing differences in gene expression of the top 1,000 DEGs in ISC niche of inflamed SAMP-25 and of inflammation-free (SAMP-5 and AKR-25) mice. Expression values are log2-transformed median-centered fragments per kilobase of transcript per million reads mapped. Red and blue colors represent increased and decreased gene expression compared with ISC niche from inflammation-free mice, respectively. We used a 5% false discovery rate (FDR-adjusted q ≤ 0.05) as the criteria for defining DEGs. Heatmap and hierarchical clustering of shared normalized enrichment scores from GSEA analysis performed on DEGs using (D) Hallmark (MSigDB H) and (E) curated and GO (MSigDB C2C5) signature gene sets in the ISC niche of SAMP-25 versus AKR-25 and SAMP-5 mice, respectively.

Two signaling pathways, i.e., unfolded protein response (UPR) and epithelial-mesenchymal transition (EMT) pathway, were enriched in the SAMP ISC niche compared with that of the AKR-25 mice, suggestive of Paneth cell defects (p~adj~ ≤ 0.03, NES ≥ 1.3; [Figures 3](#fig3){ref-type="fig"}D, [S5](#mmc1){ref-type="supplementary-material"}B and S5C; [Table S6](#mmc1){ref-type="supplementary-material"}). In contrast, the signaling pathways depleted in the SAMP ISC niche compared with that of AKR-25 mice, were involved in ISC niche homeostasis (Wnt3a and Notch1), antioxidant defense, bile acid metabolism, UV response, and in xenobiotic metabolism (p~adj~ ≤ 0.02, NES ≤ −1.4; [Figures 3](#fig3){ref-type="fig"}D, 3E, and [S5](#mmc1){ref-type="supplementary-material"}F--S5I; [Table S6](#mmc1){ref-type="supplementary-material"}).

Collectively, these data suggest that multiple signaling pathways contribute to ISC niche defect in SAMP mice, and that key biological functions appear to be already altered before inflammation onset and are further dysregulated after inflammation.

Treatment with High Wnt Medium Partially Rescues Organoid Morphology but Not the Molecular Signature in Inflammation-free SAMP Mice {#sec2.4}
-----------------------------------------------------------------------------------------------------------------------------------

Seminal studies have identified Paneth cells in the ISC niche as a major source of Wnt ([@bib45], [@bib46]; [@bib47]). Considering that Paneth cell viability and function were impaired and Wnt3a signaling pathway was depleted in the SAMP ISC niche compared with that of AKR mice, we investigated whether culturing SAMP crypts in a high Wnt3a-enriched medium ([@bib45], [@bib46]) could restore EnO formation defects. Approximately 40% of SAMP-5 crypts produced simple EnSs, while the remaining crypts generated EnOs characterized by 34% bigger size (1 ± 0.1 versus 0.7 ± 0.1, p ≤ 0.02; [Figures 4](#fig4){ref-type="fig"}A and 4B), 1.6-fold increased viability (0.6 ± 0.2 versus 0.4 ± 0.1, p ≤ 0.04; [Figure 4](#fig4){ref-type="fig"}C), and much more complex branching morphology ([Figure 4](#fig4){ref-type="fig"}D), when cultured in high Wnt-3A-conditioned medium (Wnt3a-CM) compared with those expanded in standard Intesticult (IC) medium. These specific morphological phenotypes were retained at passaging. However, generating SAMP-5 crypts in a Wnt3a-CM did not alter the number of EnSs and EnOs generated compared with those obtained in IC medium ([Figure 4](#fig4){ref-type="fig"}E). Crypts from AKR-5 control mice generated 3.3-fold bigger EnOs characterized by higher viability and multilobulated structures when cultured in Wnt3a-CM compared with those expanded in IC medium ([Figures 4](#fig4){ref-type="fig"}A--4E). Collectively, these data suggest that high Wnt3a-enriched medium partially rescues SAMP-5 EnO morphology, leading to formation of EnOs with size comparable with that of AKR-5 EnOs cultured in IC medium but smaller than AKR-5 EnOs in Wnt3a-CM. Furthermore, crypts from inflamed SAMP-25 mice were not able to round up to form viable EnS or EnO structures in the Wnt3a-CM (data not shown), similarly to those cultured in standard IC medium ([Figures 2](#fig2){ref-type="fig"}D--2G), which is likely due to marked cell death of ISCs in SAMP-25 mice.Figure 4Wnt3a-Conditioned Medium Partially Rescues EnO Size from SAMP-5 Crypts but Not Dysregulated Molecular SignatureData, indicated as mean ± SD, correspond to four independent experiments (n = 1 mouse/group/experiment).(A--E) (A and B) Growth, (C) viability, (D) number, and (E) morphology, quantification of *de novo* crypt formation of 6-day-old EnOs from 5-week-old AKR and SAMP mice cultured in Intesticult (IC) and in Wnt3a-conditioned medium (Wnt3a-CM). Scale bars, 100 μm.(F) Protein levels of indicated cytokines in AKR-5 and SAMP-5 EnOs cultures in IC or Wnt3a-CM medium. EnOs were passaged twice retaining the observed phenotype.

To gain a better insight into the biological significance of impaired EnO formation observed in *ex vivo* crypt cultures from SAMP-5 mice, we analyzed the expression of genes involved in intestinal secretory cell functions (*Defa1*, *Muc2*, and *Lyz*) in SAMP-5 EnOs cultured in IC and Wnt3a-CM. Regardless of the culturing medium used, the expression of these genes was dysregulated in SAMP-5 EnOs ([Figure S5](#mmc1){ref-type="supplementary-material"}J), suggesting defective function of multiple secretory cell lineages.

Our RNA-seq data indicate that ISC niche defect in SAMP mice is the result of dysregulation in multiple signaling pathways, including inflammation-related pathways. Therefore, we assessed the baseline level of cytokine secretion of EnOs passaged twice revealing that, regardless of the culture medium used, SAMP-5 EnOs produced 2- to 10-fold higher level of interleukin-6 (IL-6), TNF-α, and IFN-γ compared with AKR EnOs (p ≤ 0.01; [Figure 4](#fig4){ref-type="fig"}F). Thus, our data show that SAMP-5 EnOs before tissue manifestation of small intestinal inflammation have deficiency of Wnt3a and are able to be rescued by Wnt3a supplementation, albeit partially due to a component of inflammation as well.

Treatment with Dexamethasone Partially Rescues Organoid Morphology in SAMP Mice with Established Ileitis {#sec2.5}
--------------------------------------------------------------------------------------------------------

To investigate whether reduction of inflammation in SAMP-25 mice may correct organoid formation defect, we generated EnOs from SAMP-25 mice treated with dexamethasone (SAMPDex-25). The treatment dramatically reduced inflammation, infiltration of acute and chronic immune cells, and villous blunting compared with non-treated SAMP mice (p ≤ 0.01; [Figures 5](#fig5){ref-type="fig"}A--5C). Ileal crypts from SAMPDex-25 mice were able to round up to EnSs and generate viable EnOs ([Figures 5](#fig5){ref-type="fig"}D and 5E) with measurable surface area ([Figure 5](#fig5){ref-type="fig"}F) and multilobulated structures ([Figure 5](#fig5){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}A--S6D). However, dexamethasone treatment only partially rescued organoid morphology in SAMP-25 mice, since SAMPDex-25 EnSs and EnOs were, approximately, 50% less viable and 2.5-fold smaller than those from AKR-25 mice ([Figures 5](#fig5){ref-type="fig"}E and 5F; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). The number of SAMPDex-25 EnSs and EnOs generated from an equal count of seeded crypts was on average 1.3-fold lower than that of AKR-25 mice over 6 days in culture ([Figure S6](#mmc1){ref-type="supplementary-material"}D; Table S3). In addition, SAMPDex-25 EnO cultures displayed a higher recurrence of cyst-like structures and a lower *de novo* appearance of two or more regenerating crypts compared with AKR-25 EnOs (27% versus 13% and 54% versus 65%, respectively) ([Figure 5](#fig5){ref-type="fig"}G; [Table S4](#mmc1){ref-type="supplementary-material"}). Small intestines from SAMPDex-25 mice displayed comparable numbers of both ISCs and Paneth cells compared with those from AKR-25 mice, albeit with a decreasing trend ([Figures 5](#fig5){ref-type="fig"}H and 5I). Crypts from SAMPDex-25 mice harbored a frequency of dead cells in CBC and Paneth cell populations comparable with that in crypts from control mice, albeit with a decreasing trend ([Figure 5](#fig5){ref-type="fig"}J). The frequency of dead cells in CBC and Paneth cell populations was equivalent in EnOs from SAMPDex-25 and AKR-25 mice ([Figure 5](#fig5){ref-type="fig"}K), suggesting that dexamethasone treatment rescues EnO formation by enhancing the survival of Paneth cells and ISCs.Figure 5Dexamethasone Treatment Partially Rescues EnO Formation in Inflamed SAMP MiceData, indicated as mean ± SD, correspond to three independent experiments (n = 1--2 mice/group/experiment).(A) Representative photomicrographs of ileal sections of 25-week-old dexamethasone-treated SAMP (SAMPDex-25), SAMP (SAMP-25), and AKR (AKR-25) mice. Scale bars, 200 μm. Zoomed images are at 20× magnification.(B) Total inflammatory score of ileal tissue from SAMPDex-25 (4.8 ± 1.5), SAMP-25 (19.9 ± 2.6), and AKR-25 (0 ± 0) mice.(C) Relative expression of indicated cytokine mRNA measured in total tissue RNA extracted from SAMPDex-25, SAMP-25, and AKR-25 ilea. The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^).(D--F) (D) Growth, (E) viability, (F) size, and *de novo* crypt quantification of small intestinal 6-day-old EnO from SAMPDex-25, SAMP-5, and AKR-5 mice. Scale bars, 100 μm.(G) *De novo* crypt quantification of small intestinal 6-day-old EnO from AKR-25, SAMP-25, and SAMPDex-25 mice. Scale bars, 100 μm.(H--L) (H) OLFM4 and (I) LYSOZYME staining of AKR-25, SAMP-25, and SAMPDex-25 small intestinal crypts. Scale bars, 50 μm. Frequency of live and dead CBC stem cells (Epcam^+^ Ephb2^hi^/CD44^hi^GRP78^low^/CD166^+^ CD24^med^/CD31^−^CD45^−^) and Paneth cells (CD24^hi^UEA^+^/CD31^−^CD45^−^) isolated from (J) crypts and (K) EnOs of AKR-25, SAMP-25, and SAMPDex-25 mice. Relative expression of indicated genes measured in (L) total tissue or in (M) EnOs. The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^).

It is known that dexamethasone is a potent anti-inflammatory therapeutic agent able to repress nuclear factor κB (NF-κB) transcriptional activation ([@bib2]; [@bib51]). Therefore, we investigated the expression of *Nfkb1* and two other inflammation-induced genes (i.e., *Jak1* and *Mmp9*), which were found by Nanostring analyses to be strongly upregulated (\>2- to 7-fold) in the ileum of SAMP mice ([@bib8]). Our data showed that dexamethasone treatment decreased inflammation by downregulating the expression of *Nfkb1*, *Jak1*, and *Mmp9* in the ileum of SAMP mice, restoring gene expression to control mice level ([Figure 5](#fig5){ref-type="fig"}L). Interestingly, SAMPDex-25 EnOs continued to show downregulation of *Nfkb1* and *Jak1* expression compared with AKR-25 EnOs ([Figure 5](#fig5){ref-type="fig"}M). Overall, these data support the hypothesis that the inflammatory environment of CD negatively alters the ability of intestinal crypts to generate organoid structures. Finally, we demonstrated that reduction of inflammation may rescue EnO morphology in SAMP mice, albeit the recovery is not complete.

Crypts from the Distal Ileum of Young TNF Mice Display Impaired EnO Formation {#sec2.6}
-----------------------------------------------------------------------------

To confirm the role of inflammation on EnO formation, we used heterozygous TNF mice as a genetically driven murine model for CD-like ileitis ([@bib23]). TNF mice continuously produce TNF-α, have evidence of inflammation at birth ([@bib18]). The disease in TNF mice is mostly confined to the terminal ileum, with a *Tnf* mRNA transcript 6- to 40-fold higher than that present in the terminal ileum of control C57BL/6 (BL) mice ([Figures 6](#fig6){ref-type="fig"} and [7](#fig7){ref-type="fig"}C). Notably, sustained TNF-α production is known for inducing apoptosis in intestinal epithelial cell (IEC) and dose-dependent cell death in organoids ([@bib6]; [@bib15]; [@bib22]; [@bib42]).Figure 6Crypts from the Distal Ileum of Low-Grade Inflamed TNF Mice Form Rudimentary EnOsData are indicated as mean ± SD. The distal parts of the ileum of three TNF-5 mice were pooled together and two independent experiment were carried out. Whereas, two mice/group were used to generate TNFp-5 and BL-5 data, in three independent experiments.(A) Representative photomicrographs of ileal sections from 5-week-old C57BL/6 (BL-5) and of the distal ileum (TNFd-5) and proximal small intestine (TNFp-5) from 5-week-old TNF mice. Scale bars, 200 μm. Zoomed images are at 20× magnification.(B) Total inflammatory score of ileal tissue from BL-5 (0.0 ± 0.0), TNFd-5 (4.3 ± 1.4), and TNFp-5 (0.3 ± 0.5) mice.(C) Relative expression of *Tnf-α* mRNA measured in total tissue RNA extracted from TNFd-5, TNFp-5 ilea, and from the distal and proximal portion of the ileum of BL-5 mice (BLd-5 and BLp-5, respectively). The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^).(D--G) (D) Growth, (E) viability, (F) size, and (G) *de novo* crypt quantification of small intestinal 6-day-old EnO from TNFd-5, TNFp-5, and BL-5 mice. Scale bars, 100 μm.(H and I) (H) OLFM4 and (I) LYSOZYME staining of BL-5 and TNFd-5 small intestinal crypts. Scale bars, 50 μm. Frequency of live and dead CBC stem cells (Epcam^+^ Ephb2^hi^/CD44^hi^GRP78^low^/CD166^+^ CD24^med^/CD31^−^CD45^−^) and Paneth cells (CD24^hi^UEA^+^/CD31^−^CD45^−^) isolated from (J) crypts and (K) EnOs of BL-5 and TNFd-5 mice.

In light of our data, we used the proximal small intestine (jejunum) in 5- and 25-week-old TNF mice as our corresponding model for small intestinal areas where morphological features of tissue inflammation are absent. Crypts from the distal part of the ileum and from the jejunum of TNF mice at 5 weeks of age (TNFd-5 and TNFp-5, respectively) were isolated and EnOs were generated for comparison analysis to age/sex-matched inflammation-free control mice (BL-5). TNF mice had no histological evidence of inflammation in the jejunum, although presence of low-grade inflammation in the distal ileum was identified ([Figures 6](#fig6){ref-type="fig"}A--6C). Furthermore, the TNFd-5 ileum had nearly 6-fold higher expression of TNF compared with TNFp-5 and BL-5 mice, which corresponded to increased disease severity and impaired ability to form EnOs ([Figures 6](#fig6){ref-type="fig"}B and 6C). TNFd-5 mice generated a low yield of rudimentary EnOs, which contrasted the EnOs generated from TNFp-5 and BL-5 mice, which consistently recapitulated the typical multilobulated phenotype, leading to formation of cyst-like budding and branching structures over time ([Figure 6](#fig6){ref-type="fig"}D). There was a 57.5% lower viability ([Figure 6](#fig6){ref-type="fig"}E) and number of TNFd-5 generated EnSs (2-fold) and EnOs (10-fold) compared with those from TNFp-5 and BL-5 mice ([Figures S7](#mmc1){ref-type="supplementary-material"}A--S7D; [Tables S1--S3](#mmc1){ref-type="supplementary-material"}). Although of similar size ([Figures 6](#fig6){ref-type="fig"}F), 58% of the structures generated by TNFd-5 crypts were primarily spherical, in contrast to only 10% from TNFp-5 and BL-5 mice ([Figure 6](#fig6){ref-type="fig"}G; [Table S4](#mmc1){ref-type="supplementary-material"}). Distal ileum from TNF-5 mice displayed reduced number of both ISCs (5.0 ± 0.5 versus 7.0 ± 0.0, p = 0.006; [Figure 6](#fig6){ref-type="fig"}H) and Paneth cells (3.1 ± 0.5 versus 5.1 ± 0.2, p = 0.005; [Figure 6](#fig6){ref-type="fig"}I) compared with that from BL-5 mice. In addition, TNFd-5 crypts and EnOs had a markedly higher percentage of dead cells in CBC stem cell (59.1% ± 13.3% versus 24.3% ± 3.1% and 46.7% ± 7.9% versus 14.6% ± 2.1%, p ≤ 0.02; [Figures 6](#fig6){ref-type="fig"}J and 6K) and Paneth cell populations (81.2% ± 12.8% versus 17.6% ± 5.5% and 73.9% ± 8.6% versus 18.7% ± 0.9%, p \< 0.0001; [Figures 6](#fig6){ref-type="fig"}J and 6K) compared with those from control BL-5 mice.

Our data demonstrate that EnO formation is impaired when crypts are obtained from tissue that has low-grade inflammation with increased TNF, while absence of inflammation in the same tissue (proximal ileum of TNF mice) with normal TNF expression leads to normal EnO formation.

Crypts from the Distal Ileum of Inflamed TNF Mice Are Unable to Form EnOs {#sec2.7}
-------------------------------------------------------------------------

To further confirm the role of chronic inflammation in EnO formation, crypts from the distal ileum and jejunum of 25-week-old TNF mice (TNFd-25 and TNFp-25, respectively) were isolated and EnOs were generated and compared with those from controls (BL-25). While pathological features were absent in tissues from TNFp-25 and BL-25 mice, increased infiltration of acute and chronic immune cells, villous blunting phenotype, and high inflammatory score of ileal tissues were detected in TNFd-25 mice (p \< 0.0001; [Figures 7](#fig7){ref-type="fig"}A and 7B). Furthermore, in this study we demonstrated the segmental differential expression of *Tnf* between the distal and proximal ileum with 7-fold higher expression of *Tnf* in the distal ileum (tissue at 3 cm from the distal part of the ileum versus the proximal part of the ileum at 10 cm) ([Figure 7](#fig7){ref-type="fig"}C), which also corresponded to increased disease severity on histological evaluation. Crypts from TNFp-25 and BL-25 mice formed branching EnOs, which equally recapitulated the typical multilobulated phenotype ([Figures 7](#fig7){ref-type="fig"}D--7G and [S7](#mmc1){ref-type="supplementary-material"}E--S7H; [Tables S1--S4](#mmc1){ref-type="supplementary-material"}). In contrast, crypts from TNFd-25 mice were 6-fold less viable than those from BL-25 mice, of which few rounded up to form EnSs, and died by day 2 in culture ([Figures 7](#fig7){ref-type="fig"}D, 7E, and [S7](#mmc1){ref-type="supplementary-material"}F; [Table S1](#mmc1){ref-type="supplementary-material"}). Distal ileum from TNF-25 mice displayed reduced number of both ISCs (3.4 ± 0.8 versus 6.0 ± 1.0, p = 0.004; [Figure 7](#fig7){ref-type="fig"}H) and Paneth cells (1.8 ± 1.8 versus 5.0 ± 0.3, p = 0.007; [Figure 7](#fig7){ref-type="fig"}I) compared with those from BL-25 mice. In addition, TNFd-25 crypts had a markedly higher percentage of dead cells in CBC stem cell and Paneth cell populations (67.1% ± 4.1% versus 27.5% ± 8.2% and 84.5% ± 7.1% versus 30.3% ± 4.6%, p \< 0.0001; [Figure 7](#fig7){ref-type="fig"}J) compared with those from control BL-25 mice.Figure 7Crypts from the Distal Ileum of Highly Inflamed TNF Mice do Not Form EnSsData are indicated as mean ± SD. The distal parts of the ileum of three TNF-25 mice were pooled together and two independent experiment were carried out. Whereas, two mice/group were used to generate TNFp-25 and BL-25 data in three independent experiments.(A) Representative photomicrographs of ileal sections from 25-week-old C57BL/6 (BL-25) and of the ileum (TNFd-25) and proximal small intestine (TNFp-25) from 25-week-old TNF mice. Scale bars, 200 μm. Zoomed images are at 20× magnification.(B) Total histologic score of ileal tissue from BL-25 (0.0 ± 0.0), TNFd-25 (26.8 ± 5.8), and TNFp-25 (1.7 ± 1.4) mice.(C) Segmental differential expression of *Tnf* mRNA between the distal and proximal ileum of TNF-25 and BL-25 mice, with 7-fold higher expression of *Tnf* in the distal ileum (tissue at 3 cm from the distal part of the ileum versus that at 10 cm). The mRNA levels were determined by qRT-PCR, normalized to β-actin and expressed as fold change (2^−ΔΔCt^).(D--G) (D) Growth, (E) viability, (F) size, and (G) *de novo* crypt quantification of small intestinal 6-day-old EnO from TNFd-25, TNFp-25, and BL-25 mice. Scale bars, 100 μm.(H--J) (H) OLFM4 and (I) LYSOZYME staining of BL-25 and TNFd-25 small intestinal crypts. Scale bars, 50 μm.(J) Frequency of live and dead CBC stem cells (Epcam^+^ Ephb2^hi^/CD44^hi^GRP78^low^/CD166^+^ CD24^med^/CD31^−^CD45^−^) and Paneth cells (CD24^hi^UEA^+^/CD31^−^CD45^−^) isolated from crypts of BL-25 and TNFd-25 mice.

Considering that, similar to SAMP mice, TNF mice do not develop disease or display inflammation in the colon, TNF-25 colon crypts successfully round up to form CnSs leading to CnO formation ([Figures S3](#mmc1){ref-type="supplementary-material"}D--S3F). In this context, our data collectively suggest that crypts of highly inflamed ileal tissues from TNF mice are unable to form organoid structures and this correlated to the high TNF expression and reduced viability of ISCs and Paneth cells.

Discussion {#sec3}
==========

In this study, we developed a translationally relevant EnO-based model from ileitis-prone mice that recapitulate the epithelial cell phenotype of CD-like ileitis, and can be used to study IEBD in experimental CD and to identify and test novel therapies to correct this defect. Our study demonstrates that EnOs obtained from non-inflamed parental control mice resemble the 3D morphology of a healthy gut, while those from inflammation-free (but CD predisposed) 5-week-old SAMP mice display impaired formation. The Olson et al. study had demonstrated that SAMP mice develop a significant small intestine epithelial barrier dysfunction at a very early age, which precedes the onset of intestinal inflammation. Multiple studies in other animal models of IBD, including IL-10^−/−^ ([@bib29]) and mdr1a^−/−^ mice ([@bib40]), and in human studies have provided strong supporting evidence for epithelial barrier dysfunction preceding the onset of intestinal inflammation, thus suggesting a prominent role for IEBD early in disease development. Notably, inflammation-free SAMP EnOs produced an exacerbated expression profile of genes involved in epithelial secretory cell functions and a proinflammatory secreted cytokine profile. The exacerbated expression and cytokine profile, which is maintained in *ex vivo* expanded epithelial organoids from 5-week-old SAMP mice, demonstrates that SAMP EnOs recapitulate reactive epithelial changes specific of experimental CD. This aspect is of paramount importance as it emphasizes the physiologically relevant value of organoids generated from the SAMP mice model, rather than those originated from healthy individuals, to mimic CD-like ileitis. This culture system holds exciting translational value since it may be used as an *in vivo* and *in vitro* drug-screening platform to test for therapies that can correct IEBD. Furthermore, multiple other immune-mediated diseases, such as celiac disease, type 1 diabetes ([@bib36]), and nonalcoholic steatohepatitis ([@bib28]) have been associated with IEBD and, thus, our model system provides a relevant platform to test therapies in the context of various disease states. Previous studies have used gastrointestinal organoids isolated from healthy donors to study infectious diseases, e.g., *Salmonella typhimurium* or *Clostridium difficile* ([@bib26]; [@bib57]); however, these models hold limited biological relevance for the study of CD, a complex and progressive inflammatory disease associated with more than 200 susceptibility loci ([@bib27]). Our EnO model system is ideally suited to perform functional studies of host epithelium-microbial interactions in experimental CD.

Our study demonstrated that a highly inflammatory environment, such as the ileal milieu of 25-week-old SAMP mice and that of the distal ileum of TNF mice, impedes EnO formation, and that this is in stark contrast to the functional organoid formation seen in the same mice using non-inflamed tissues (e.g., colon), or in tissues from younger, "non-inflamed" mice (i.e., before ileitis onset). Intuitively, this makes sense as excessive cell death has been demonstrated in the lamina propria of highly inflamed areas in mice models and patients with CD ([@bib6]; [@bib15]; [@bib22]; [@bib42]). The role of inflammation in shaping the ISC niche is increasingly being recognized, with recent studies suggesting a crosstalk between immune cells and ISCs ([@bib32]; [@bib43]). For instance, in one recent landmark study, [@bib5] demonstrated that the interaction of ISCs with T helper cells determines their fate with proinflammatory Th1, Th2, and Th17 cells and their cytokines, guiding a specific ISC differentiation and depletion/destruction, whereas co-culture with anti-inflammatory T~regs~ or IL-10 promoted ISC renewal. To exclude the effect of immune cells on ISC differentiation, we passaged EnOs at least twice. Similar to the Biton study, we demonstrated that crypts from SAMP mice with established severe inflammation had markedly reduced number of viable ISCs and viable Paneth cells, and diminished ability to form EnOs. Furthermore, mitigating inflammation through steroid (dexamethasone) treatment improves EnO generation and enhances the survival/viability of Paneth cells and ISCs. In the TNF mice, a genetically driven model of CD that is characterized by a continuous, aberrant TNF production, the ability to form EnOs correlates with degree of inflammation and TNF expression, e.g., crypts obtained from distal ileum of 25-week-old TNF mice with highest histologic scores corresponding to highest levels of TNF expression and inability to form EnOs. Sustained TNF-α production is known for inducing apoptosis in IECs of CD patient and mouse models of CD ([@bib6]; [@bib22]; [@bib42]) and dose-dependent cell death in organoids ([@bib15]). Furthermore, similar to SAMP mice, severe inflammation markedly reduced the number of viable ISCs and Paneth cells in TNF mice. Therefore, our data shows that, in TNF mice, the high TNF levels that correspond with severe inflammation are responsible for EnO formation defect.

Our data from two murine models of experimental CD demonstrate that severe inflammation impairs the ability to form EnOs. However, the results from human studies to generate EnOs from inflamed areas of patients with CD patients have been mixed. Some studies demonstrate that the number and quality of isolated crypts from inflamed regions of CD and ulcerative colitis patients is too low to regularly form intestinal organoids ([@bib11]; [@bib56]). On the other hand, some studies report that the organoid-forming capacity is similar between inflamed and non-inflamed areas of CD patients and are similar to healthy controls ([@bib11]; [@bib35]; [@bib53]; [@bib54]). We believe that, unlike our murine study, these studies have not utilized a standard scoring technique to quantify the degree of inflammation in the affected/inflamed areas of CD patients. Future studies using large numbers of CD patients with assessment of inflammation in diseased and non-diseased areas with correlation to EnO formation ability and medium conditions are warranted.

SAMP mice, even before the onset of ileitis, exhibit a primary alteration of epithelial function ([@bib37]), especially Paneth cells, as we show in this study. A recent pivotal study by [@bib21] found dysregulation of the colonic ISC niche in ulcerative colitis patients and highlighted how the colitis milieu drives stem cell niche dysregulation and leads to impaired epithelial development and barrier dysfunction. Dissecting the molecular pathways mediating barrier protection and dysfunction in the ISC niche is crucial for identifying the EnO defect and for developing strategies to reverse IEBD. Therefore, we generated the first global gene expression profile analysis of the SAMP ISC niche, and identified multiple signaling pathways already altered in young mice before histological detection of inflammation, suggesting their potential implication in disease development. Among these, the EMT pathway, which was highly enriched in the SAMP ISC niche, is well known to be implicated in fibrosis, which is a feature of human CD as well as of ileitis in SAMP mice ([@bib19]; [@bib48]). The process of both stem cell self-renewal and differentiation is coordinated by many signaling pathways, such as Notch and Wnt. Aberrancies in genes belonging to such pathways and their expression levels can influence these processes, leading to loss of stemness and of intestinal homeostasis ([@bib14]; [@bib38]; [@bib44]). Even before inflammation development, the Wnt3a-signaling pathway was found depleted in the ISC niche of 5-week-old SAMP mice in our RNA-seq experiment, and in Paneth cells, a major source of Wnt ([@bib45], [@bib46]; [@bib47]), had decreased viability and functionality. These data are in agreement with the concept that Paneth cells constitute the key niche to support Lgr5^+^ stem cells ([@bib45], [@bib46]). Using a high Wnt3a-enriched medium in 5-week-old SAMP mice with absence of inflammation, we were successful in partially rescuing EnO morphology *in vitro*. Enteroid morphology was only partially restored in 5-week-old SAMP mice because multiple pathways are defective in these mice. Another pathway highly activated in the SAMP ISC niche was the UPR signaling, which critically regulates intestinal epithelial stem cell differentiation ([@bib17]) and affects the development of chronic inflammation ([@bib20]; [@bib50]). UPR activation in IECs and immune cells has been shown to result in NF-κB-mediated induction and secretion of proinflammatory cytokines, such as IL-6 and TNF ([@bib16]). Our data show that dexamethasone treatment of SAMP mice results in downregulating the expression of proinflammatory NF-κB and partial rescue of organoid formation. However, steroids such as dexamethasone are potent and broad immunosuppressive agents and likely mediate their effect through multiple pathways. Our future studies will focus on more specific approaches to modulate the UPR signaling pathway. Thus, an improved understanding of the relationship between stem cells and their niches will facilitate the *in vivo* manipulation of the niche to modulate endogenous stem cell function, yielding new and improved stem-cell-based therapies.

Finally, EnOs generated from two mouse models of CD have defective formation and they can be used as a preclinical model to understand the role of IEBD in CD pathogenesis and to develop and test novel therapies.

Experimental Procedures {#sec4}
=======================

Detailed methods are provided in [Supplemental Information](#mmc1){ref-type="supplementary-material"}.

Experimental Animals {#sec4.1}
--------------------

Five- and 25-week-old male SAMP and TNF mice, and age/gender-matched AKR/J (AKR) and BL control mice were used.

Mouse Intestinal Organoid Isolation, Culture, and Passage {#sec4.2}
---------------------------------------------------------

Intestinal crypts were cultured as described previously ([@bib47]), and every 6 days- EnOs were passaged dissolving Matrigel in cold PBS. EnOs passaged twice were grown for an additional 6 days and then gene and protein expression and cytokine secretion were measured.

Organoid Measurement {#sec4.3}
--------------------

The surface area of EnO horizontal cross-sections was measured by acquiring nine non-overlapping pictures representing approximately the whole area of a single Matrigel dome ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B) using an Olympus CKX53 inverted microscope, and then analyzed using ImageJ software.

Assessment of Crypt Viability via MTT Reduction {#sec4.4}
-----------------------------------------------

Organoid viability was assessed over time by MTT assay.

Histology and Immunohistochemistry {#sec4.5}
----------------------------------

Tissue collection and preparation for histological evaluation and immunohistochemistry was carried out as described previously ([@bib7]; [@bib45], [@bib46]).

Scanning Electron Microscopy {#sec4.6}
----------------------------

EnO morphology and ultrastructure was analyzed using scanning electron microscopy (SEM).

Dexamethasone Treatment {#sec4.7}
-----------------------

Animals were treated with either dexamethasone (4 mg kg^−1^, every 24 h, intraperitoneal, for 7 days) or saline solution, as control.

RNA Isolation, Reverse Transcription, and Real-Time PCR {#sec4.8}
-------------------------------------------------------

Primers used are described in [Table S5](#mmc1){ref-type="supplementary-material"}.

Cytokine Assays {#sec4.9}
---------------

Cytokine levels were measured in EnO supernatants using BD Cytometric Bead Array Mouse Inflammation Kit in accordance with the manufacturer\'s instructions.

LCM of ISC Niche and Sample Preparation for RNA-Seq {#sec4.10}
---------------------------------------------------

ISC niche was collected by LCM and sample preparation for RNA-seq was performed by BGI Tech (Beijing Genomic Institute, Shenzhen, China)

Data Analysis and Functional Analysis of DEGs {#sec4.11}
---------------------------------------------

Data are available at GEO (Gene Expression Omnibus, accession number [GSE124825](ncbi-geo:GSE124825){#intref0010}).

Statistical Analysis {#sec4.12}
--------------------

Statistical analysis was carried out with GraphPad Prism (version 6.0; GraphPad Software, San Diego, CA). For comparison between two groups, Student\'s two-tailed unpaired t test or Mann-Whitney test was used. For comparison between more than two groups one-way ANOVA test with Bonferroni as *post-hoc* test was applied. p ≤ 0.05 was considered significant. Each data point corresponds to a single mouse. Data are reported as mean ± SD. Number of independent experiments is indicated in each figure legend. Each data point in the figure represents one mouse.

Data and Code Availability {#sec4.13}
--------------------------

Data are available at GEO (Gene Expression Omnibus, accession number [GSE124825](ncbi-geo:GSE124825){#intref0015}).

Author Contributions {#sec5}
====================

M.D. conceptualized and designed the study. L.F.B. designed and performed the experiments, and analyzed the data. S.M. performed immunohistochemistry. L.F.B. and N.Z. performed the dexamethasone treatment experiment. A.O. performed the histopathology evaluation of samples. C.L.H. and M.A.G. carried out SEM assay. A.P. performed RNA-seq and GSEA data analysis. L.F.B. and M.D. interpreted data and wrote the manuscript. M.D., R.-P.S., and F.C. edited the manuscript regarding content and interpretation. All authors read, commented and approved final manuscript.

Supplemental Information {#app2}
========================

Document S1. Supplemental Experimental Procedures, Figures S1--S7, and Tables S1--S6Document S2. Article plus Supplemental Information

The authors thank Dr. Abigail R. Basson, Dr. Minh Lam, and Dr. Charles L. Bevins for critical proofreading of the manuscript, Dr. Patrick Leahy for assistance with laser capture microdissection microscopy, and Ms. Natalia Aladyshkina and Mr. Joshua Webster for assistance with animal husbandry. We also thank the Core services provided by the Cleveland Digestive Research Core Center and the Laser Capture Core. We would like to thank Dr. Noah Freeman Shroyer, Director Organoid/GEMS core of Baylor College of Medicine, Houston, TX, for providing us the high Wnt3a-enriched medium. This work was supported by Crohn's and Colitis Foundation Career Development Award 370615 (to M.D.), 10.13039/100000002NIH grants: K08DK110421 (to M.D.), P30DK097948 and DK042191 (to F.C.), DK091222 (to F.C.), DK07948 (to F.C.), and R01AI145289-01A1 (to M.A.G.). The funding agencies had no role in the study analysis or writing of the manuscript. Its contents are solely the responsibility of the authors.

Supplemental Information can be found online at <https://doi.org/10.1016/j.stemcr.2020.06.017>.

[^1]: Co-senior author
